55289-477 : Viracept 250 mg Oral Tablet


NDC: 55289-477
Labeler: Pd-rx Pharmaceuticals, Inc.
Product Type: Human Prescription Drug
Drug Name:  Viracept
Dosage Form: Oral Tablet, Film Coated
Application #: NDA020779
Rev. Date: 


Appearance:


Markings: VIRACEPT;250;mg
Shapes:  Oval
Colors:  Blue
Size (mm): 19
Segments: * 1

* Segments = the number of equally sized pieces which the pill can be broken into. In this case, a value of 1 indicates a solid pill with no score lines.

VIRACEPT 250 mg: (63010-010) Viracept 250 mg Oral Tablet by Pd-rx Pharmaceuticals, Inc.
The above image is provided by the U.S. National Library of Medicine (NLM) and is not part of the official label.

NDC Package Codes:

  • 55289-477-27: 27 TABLET, FILM COATED IN 1 BOTTLE, PLASTIC (55289‑477‑27)

Active Ingredients:

  • Nelfinavir Mesylate

Dosage Strength:

  • 250 mg

Inactive Ingredients:

  • Calcium Silicate
  • Crospovidone
  • Magnesium Stearate
  • Hypromelloses
  • Triacetin
  • Fd&c Blue No. 2

Pharmaceutical Classes:

  • HIV Protease Inhibitors [MoA]
  • Protease Inhibitor [EPC]
  • Cytochrome P450 3A Inhibitors [MoA]

Related Products:

Based on records with the same trade name.
  • 24236-287 Viracept 625 mg Oral Tablet by Remedyrepack Inc.
  • 52959-289 Viracept 250 mg Oral Tablet by H.j. Harkins Company, Inc.
  • 53808-0809 Viracept 625 mg Oral Tablet by State of Florida Doh Central Pharmacy
  • 63010-010 Viracept 250 mg Oral Tablet by Agouron Pharmaceuticals Inc
  • 63010-011 Viracept 50 mg/g Oral Powder by Agouron Pharmaceuticals Inc
  • 63010-027 Viracept 625 mg Oral Tablet by Agouron Pharmaceuticals Inc

NDC QR Code

Scan the QR code below to easily reference this data in the future:

NDC 55289-477 QR Code

< Prev: 55289-475Next: 55289-479 >




Note: The RxChat NDC Database uses publicly available data from the FDA and the U.S. National Library of Medicine (NLM); The NLM is not responsible for the data presented and does not endorse or recommend this or any other product. While we make every effort to ensure that the information presented is accurate, you should assume that all results are unvalidated. To report any errors or inconsistencies please contact us.